| 2.1 |
6.4 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 1.7 |
5.1 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 1.5 |
5.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.4 |
4.3 |
GO:0046015 |
carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 1.3 |
5.2 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 1.2 |
3.5 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 1.2 |
3.5 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 1.2 |
8.3 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 1.0 |
4.1 |
GO:0048935 |
peripheral nervous system neuron development(GO:0048935) |
| 0.9 |
2.7 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.8 |
4.0 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.8 |
3.2 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.8 |
2.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.8 |
4.6 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.8 |
3.0 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.7 |
2.8 |
GO:0046671 |
regulation of nitrogen utilization(GO:0006808) positive regulation of neuron maturation(GO:0014042) nitrogen utilization(GO:0019740) cochlear nucleus development(GO:0021747) negative regulation of cellular pH reduction(GO:0032848) glial cell apoptotic process(GO:0034349) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) positive regulation of cell maturation(GO:1903431) |
| 0.7 |
0.7 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.7 |
2.0 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.7 |
2.7 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.7 |
0.7 |
GO:0070304 |
positive regulation of stress-activated MAPK cascade(GO:0032874) positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
| 0.6 |
1.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.6 |
1.9 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.6 |
4.9 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.6 |
0.6 |
GO:0003149 |
membranous septum morphogenesis(GO:0003149) |
| 0.5 |
4.3 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.5 |
5.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.5 |
1.6 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.5 |
1.5 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.5 |
1.5 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.5 |
2.5 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.5 |
1.0 |
GO:1904036 |
negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.5 |
3.5 |
GO:0031664 |
regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
| 0.5 |
1.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.5 |
3.5 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.5 |
1.0 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.5 |
0.9 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.5 |
2.8 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.4 |
0.9 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.4 |
1.3 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.4 |
2.2 |
GO:0021779 |
oligodendrocyte cell fate commitment(GO:0021779) |
| 0.4 |
3.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.4 |
2.6 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.4 |
1.7 |
GO:0010900 |
regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.4 |
0.4 |
GO:0046449 |
allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.4 |
2.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.4 |
3.7 |
GO:0043584 |
nose development(GO:0043584) |
| 0.4 |
1.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.4 |
3.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.4 |
1.2 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.4 |
1.6 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.4 |
1.2 |
GO:0071883 |
adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 |
1.6 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.4 |
0.4 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.4 |
2.7 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.4 |
1.9 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 |
0.8 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.4 |
1.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.4 |
0.7 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.4 |
2.2 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.4 |
0.7 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.4 |
2.2 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 |
1.4 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
| 0.4 |
1.4 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.4 |
2.5 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.3 |
0.7 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.3 |
1.0 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
0.3 |
GO:0002720 |
positive regulation of cytokine production involved in immune response(GO:0002720) |
| 0.3 |
0.7 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) regulation of histone H3-K9 methylation(GO:0051570) |
| 0.3 |
1.0 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
| 0.3 |
0.3 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.3 |
2.3 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.3 |
1.3 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
| 0.3 |
1.6 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.3 |
2.2 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
| 0.3 |
1.9 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.3 |
1.0 |
GO:0046732 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by virus of host immune response(GO:0075528) |
| 0.3 |
0.9 |
GO:0043418 |
cysteine biosynthetic process from serine(GO:0006535) homoserine metabolic process(GO:0009092) cysteine biosynthetic process via cystathionine(GO:0019343) transsulfuration(GO:0019346) homocysteine catabolic process(GO:0043418) |
| 0.3 |
1.8 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.3 |
1.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.3 |
1.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 |
0.3 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.3 |
1.5 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.3 |
0.9 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 0.3 |
0.3 |
GO:0036336 |
dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
| 0.3 |
2.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.3 |
1.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.3 |
1.1 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.3 |
0.8 |
GO:0097237 |
cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 0.3 |
2.5 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
0.8 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.3 |
1.1 |
GO:0046827 |
regulation of protein export from nucleus(GO:0046825) positive regulation of protein export from nucleus(GO:0046827) |
| 0.3 |
1.1 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 |
1.6 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.3 |
1.3 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.3 |
1.6 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.3 |
0.8 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
1.0 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.3 |
2.8 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.2 |
0.7 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.7 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.2 |
0.7 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.2 |
0.2 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.2 |
1.0 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.2 |
0.7 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.2 |
1.4 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.2 |
0.2 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.2 |
1.0 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.2 |
1.9 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.2 |
1.2 |
GO:0050686 |
negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
| 0.2 |
0.7 |
GO:0031396 |
regulation of protein ubiquitination(GO:0031396) |
| 0.2 |
0.7 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
0.2 |
GO:0010993 |
ubiquitin homeostasis(GO:0010992) regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 |
0.7 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.2 |
0.7 |
GO:0071539 |
Golgi localization(GO:0051645) protein localization to centrosome(GO:0071539) |
| 0.2 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
1.4 |
GO:0072124 |
glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) regulation of glomerulus development(GO:0090192) |
| 0.2 |
2.3 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.2 |
0.2 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.2 |
0.9 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.2 |
2.0 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.2 |
0.7 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 |
0.9 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.2 |
0.9 |
GO:0045356 |
positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.2 |
1.3 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 |
5.2 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.2 |
3.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
0.9 |
GO:0045299 |
otolith mineralization(GO:0045299) |
| 0.2 |
1.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
1.9 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.2 |
0.4 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.2 |
0.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
2.5 |
GO:0032876 |
regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
| 0.2 |
1.0 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
1.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
0.8 |
GO:0061043 |
positive regulation of vascular wound healing(GO:0035470) vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
| 0.2 |
1.0 |
GO:0010957 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.2 |
1.8 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
1.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
2.2 |
GO:1901983 |
regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
| 0.2 |
0.6 |
GO:0071848 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) TNFSF11-mediated signaling pathway(GO:0071847) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.2 |
0.6 |
GO:0007109 |
obsolete cytokinesis, completion of separation(GO:0007109) |
| 0.2 |
5.0 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.2 |
1.5 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.2 |
0.4 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.2 |
0.7 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.2 |
0.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 |
0.7 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 |
0.9 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
10.0 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
0.2 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 |
4.8 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.2 |
0.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 |
2.1 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.2 |
3.7 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.2 |
1.6 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
0.9 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
0.9 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
0.5 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.2 |
0.7 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
1.2 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.2 |
0.5 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.2 |
0.2 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.2 |
0.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
1.5 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.2 |
1.3 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
0.5 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
0.6 |
GO:0072180 |
nephric duct development(GO:0072176) mesonephric duct development(GO:0072177) nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
| 0.2 |
1.9 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
0.8 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 |
0.3 |
GO:0002740 |
negative regulation of cytokine secretion involved in immune response(GO:0002740) |
| 0.2 |
0.6 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.2 |
0.3 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.2 |
4.1 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.2 |
0.5 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) Spemann organizer formation(GO:0060061) |
| 0.2 |
0.5 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
| 0.2 |
0.5 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.2 |
0.6 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.2 |
0.5 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.2 |
0.2 |
GO:0051057 |
positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.2 |
1.4 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
1.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.1 |
0.4 |
GO:0034626 |
fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
1.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.7 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.4 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.1 |
0.1 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.1 |
0.7 |
GO:0022605 |
ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) |
| 0.1 |
0.1 |
GO:0048659 |
smooth muscle cell proliferation(GO:0048659) |
| 0.1 |
0.4 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 |
2.2 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.1 |
GO:0002890 |
negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.1 |
1.0 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.6 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.1 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.1 |
0.4 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 |
2.3 |
GO:0001662 |
behavioral fear response(GO:0001662) |
| 0.1 |
0.8 |
GO:0099515 |
nuclear migration along microfilament(GO:0031022) actin filament-based transport(GO:0099515) |
| 0.1 |
0.3 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.7 |
GO:0045953 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 |
5.1 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.8 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
2.2 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
1.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.4 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.4 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.1 |
0.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.1 |
0.9 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
2.0 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.4 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.5 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.4 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.1 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.8 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
2.0 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.7 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.4 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.9 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.1 |
0.4 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.9 |
GO:0016265 |
obsolete death(GO:0016265) |
| 0.1 |
0.6 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.3 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
0.5 |
GO:0072284 |
visceral serous pericardium development(GO:0061032) S-shaped body morphogenesis(GO:0072050) metanephric S-shaped body morphogenesis(GO:0072284) |
| 0.1 |
8.6 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
1.3 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.3 |
GO:0030431 |
sleep(GO:0030431) |
| 0.1 |
1.5 |
GO:0032608 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.5 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.1 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.6 |
GO:0032647 |
interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
| 0.1 |
0.6 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
1.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.1 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.8 |
GO:0032464 |
positive regulation of protein oligomerization(GO:0032461) positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.4 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 |
0.6 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.1 |
0.5 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
1.2 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.5 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.8 |
GO:0060487 |
lung epithelial cell differentiation(GO:0060487) |
| 0.1 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.2 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
0.6 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.2 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.2 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.1 |
0.5 |
GO:0042593 |
carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 0.1 |
0.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.8 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.4 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) |
| 0.1 |
0.4 |
GO:0035307 |
positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.1 |
0.8 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.3 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.1 |
0.1 |
GO:2000078 |
regulation of type B pancreatic cell development(GO:2000074) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.1 |
1.1 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.1 |
0.2 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.5 |
GO:0051294 |
establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
| 0.1 |
1.1 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.1 |
0.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.6 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
1.4 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 |
2.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
1.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 |
1.2 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
1.3 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.1 |
0.4 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 |
0.5 |
GO:0032099 |
negative regulation of appetite(GO:0032099) |
| 0.1 |
4.0 |
GO:0000080 |
mitotic G1 phase(GO:0000080) |
| 0.1 |
0.2 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.1 |
0.5 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.3 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.1 |
1.9 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.1 |
0.3 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.1 |
0.4 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.3 |
GO:0039656 |
modulation by virus of host gene expression(GO:0039656) |
| 0.1 |
0.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.5 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.1 |
0.2 |
GO:0006386 |
transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.1 |
0.9 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.3 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
0.3 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.4 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
4.8 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.1 |
0.3 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.1 |
0.6 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.2 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
| 0.1 |
0.8 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.4 |
GO:0051099 |
positive regulation of binding(GO:0051099) |
| 0.1 |
0.1 |
GO:0060004 |
reflex(GO:0060004) |
| 0.1 |
0.8 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.3 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.3 |
GO:0072217 |
negative regulation of metanephros development(GO:0072217) |
| 0.1 |
0.4 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.1 |
0.1 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.1 |
0.8 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.8 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.6 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
1.9 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 |
1.4 |
GO:0048260 |
positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.1 |
0.6 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
4.2 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.1 |
0.1 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
0.3 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.1 |
0.6 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.3 |
GO:0030147 |
obsolete natriuresis(GO:0030147) |
| 0.1 |
0.4 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 |
0.3 |
GO:0022601 |
menstrual cycle phase(GO:0022601) |
| 0.1 |
0.9 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.3 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.2 |
GO:0006664 |
glycolipid metabolic process(GO:0006664) |
| 0.1 |
0.2 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 |
0.4 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.1 |
0.7 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
0.7 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.4 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.3 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.1 |
0.2 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 |
1.9 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.3 |
GO:0051000 |
positive regulation of nitric-oxide synthase activity(GO:0051000) |
| 0.1 |
0.2 |
GO:0072073 |
kidney epithelium development(GO:0072073) |
| 0.1 |
1.1 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.9 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
1.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.8 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.2 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.2 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
1.0 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.1 |
0.9 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.7 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.9 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
1.7 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.3 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.2 |
GO:0044321 |
cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
| 0.1 |
0.2 |
GO:0046368 |
GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.1 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.1 |
2.6 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.1 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.1 |
0.3 |
GO:0009211 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.1 |
0.3 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.1 |
0.9 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.1 |
2.0 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
1.0 |
GO:0006448 |
regulation of translational elongation(GO:0006448) |
| 0.1 |
0.1 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
0.6 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.1 |
0.1 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.1 |
0.2 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.1 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 |
0.3 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
1.1 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.3 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.1 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.4 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) |
| 0.1 |
0.3 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
| 0.1 |
0.1 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.1 |
0.2 |
GO:0043306 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
1.5 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.1 |
1.1 |
GO:0075713 |
establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
1.1 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.1 |
0.3 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.1 |
0.3 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.5 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.1 |
0.5 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 |
6.7 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.1 |
1.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
1.4 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
1.2 |
GO:0010921 |
regulation of phosphatase activity(GO:0010921) regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.1 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) |
| 0.1 |
0.1 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.1 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.1 |
0.3 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.9 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.4 |
GO:0030099 |
myeloid cell differentiation(GO:0030099) |
| 0.1 |
1.2 |
GO:0006596 |
polyamine biosynthetic process(GO:0006596) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.1 |
0.4 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
0.4 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.1 |
GO:0021675 |
nerve development(GO:0021675) |
| 0.1 |
0.8 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
1.1 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.1 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.1 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.1 |
0.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.2 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.4 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.1 |
0.2 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 |
0.2 |
GO:0031622 |
regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
| 0.1 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.1 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.2 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.1 |
0.2 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.2 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.4 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.3 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.2 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.2 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 |
0.1 |
GO:0016046 |
cell surface pattern recognition receptor signaling pathway(GO:0002752) detection of fungus(GO:0016046) |
| 0.1 |
0.2 |
GO:0034126 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) positive regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034126) |
| 0.1 |
0.2 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.4 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
1.1 |
GO:0034968 |
histone lysine methylation(GO:0034968) |
| 0.1 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
1.1 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.5 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.1 |
0.9 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.5 |
GO:0006402 |
mRNA catabolic process(GO:0006402) |
| 0.1 |
0.3 |
GO:0043316 |
natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.1 |
4.1 |
GO:0034339 |
obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
| 0.1 |
0.4 |
GO:1902749 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.1 |
0.6 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.5 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.2 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.7 |
GO:0071333 |
cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
| 0.1 |
0.3 |
GO:0042770 |
signal transduction in response to DNA damage(GO:0042770) |
| 0.1 |
1.0 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.2 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.1 |
0.2 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 |
0.6 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.1 |
0.5 |
GO:0070189 |
kynurenine metabolic process(GO:0070189) |
| 0.1 |
0.4 |
GO:0051497 |
negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
0.4 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.3 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.2 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.1 |
0.2 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.1 |
0.3 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.2 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.1 |
0.1 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.4 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.1 |
1.0 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.1 |
0.5 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.1 |
1.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.1 |
0.2 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.1 |
0.3 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.6 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.1 |
0.3 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 |
0.3 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 |
3.0 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.2 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 |
0.4 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.1 |
0.2 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.1 |
0.2 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.1 |
0.2 |
GO:0003160 |
endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
| 0.1 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.1 |
GO:0048488 |
synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) synaptic vesicle cycle(GO:0099504) |
| 0.1 |
3.7 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.1 |
0.2 |
GO:0060079 |
excitatory postsynaptic potential(GO:0060079) |
| 0.1 |
0.2 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
4.6 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.0 |
1.8 |
GO:0009791 |
post-embryonic development(GO:0009791) |
| 0.0 |
0.6 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
1.2 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.0 |
0.1 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.0 |
4.9 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.1 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.7 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.0 |
0.2 |
GO:0071436 |
sodium ion export(GO:0071436) |
| 0.0 |
0.1 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
| 0.0 |
1.0 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.4 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.2 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.4 |
GO:0009148 |
pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.0 |
0.2 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.0 |
0.8 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.0 |
0.0 |
GO:0060872 |
semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
| 0.0 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.0 |
0.1 |
GO:0021697 |
cerebellar cortex formation(GO:0021697) |
| 0.0 |
1.3 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.0 |
0.7 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.6 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.2 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.3 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
1.1 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
2.0 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 |
0.0 |
GO:0060433 |
bronchus development(GO:0060433) |
| 0.0 |
0.1 |
GO:0044060 |
regulation of endocrine process(GO:0044060) |
| 0.0 |
0.1 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
0.4 |
GO:0016571 |
histone methylation(GO:0016571) |
| 0.0 |
0.3 |
GO:0048070 |
regulation of developmental pigmentation(GO:0048070) |
| 0.0 |
0.7 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0060896 |
neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
1.1 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.2 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.0 |
0.1 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.0 |
0.3 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 0.0 |
0.0 |
GO:0051938 |
L-glutamate import(GO:0051938) |
| 0.0 |
0.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.2 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.1 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
1.2 |
GO:0042384 |
cilium assembly(GO:0042384) |
| 0.0 |
0.3 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.1 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
0.2 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.0 |
0.2 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.0 |
0.5 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
0.0 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.2 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.0 |
0.3 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 |
0.1 |
GO:0001507 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.0 |
6.2 |
GO:0016568 |
chromatin modification(GO:0016568) |
| 0.0 |
0.9 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.2 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.2 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.3 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.1 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.0 |
0.1 |
GO:0015992 |
hydrogen transport(GO:0006818) proton transport(GO:0015992) |
| 0.0 |
0.2 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.0 |
0.1 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.1 |
GO:0050851 |
antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.0 |
0.1 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.0 |
0.4 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.0 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.6 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.0 |
0.5 |
GO:0045823 |
positive regulation of heart contraction(GO:0045823) |
| 0.0 |
0.1 |
GO:0042637 |
catagen(GO:0042637) |
| 0.0 |
0.4 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.2 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 |
0.2 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.0 |
0.2 |
GO:0032613 |
interleukin-10 production(GO:0032613) |
| 0.0 |
1.0 |
GO:0030866 |
cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.0 |
GO:0046886 |
positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.0 |
0.1 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0007418 |
ventral midline development(GO:0007418) |
| 0.0 |
0.2 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.7 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.1 |
GO:0032506 |
barrier septum assembly(GO:0000917) cytokinetic process(GO:0032506) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
| 0.0 |
0.3 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.1 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.1 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.0 |
0.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.0 |
0.3 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
0.5 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.4 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.0 |
0.1 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 |
0.1 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
1.6 |
GO:0008016 |
regulation of heart contraction(GO:0008016) |
| 0.0 |
0.2 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.4 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.9 |
GO:0030177 |
positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.0 |
0.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.4 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.0 |
0.1 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.8 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.3 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.1 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.0 |
0.3 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.0 |
0.0 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 |
0.9 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
| 0.0 |
0.7 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.0 |
0.1 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 0.0 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.7 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
0.1 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.6 |
GO:0051321 |
meiotic cell cycle(GO:0051321) |
| 0.0 |
0.1 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
0.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.4 |
GO:0002286 |
T cell activation involved in immune response(GO:0002286) |
| 0.0 |
0.6 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.0 |
0.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.3 |
GO:0045768 |
obsolete positive regulation of anti-apoptosis(GO:0045768) |
| 0.0 |
0.7 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.0 |
3.1 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.0 |
0.1 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.0 |
0.9 |
GO:0006885 |
regulation of pH(GO:0006885) |
| 0.0 |
1.7 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
2.5 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.0 |
0.1 |
GO:0051439 |
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.0 |
0.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.2 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.4 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.1 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 |
0.1 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
1.8 |
GO:0006511 |
ubiquitin-dependent protein catabolic process(GO:0006511) |
| 0.0 |
0.5 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.5 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
0.5 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.1 |
GO:0006530 |
asparagine metabolic process(GO:0006528) asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 0.0 |
0.2 |
GO:0010821 |
regulation of mitochondrion organization(GO:0010821) |
| 0.0 |
0.4 |
GO:0036503 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
| 0.0 |
2.5 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.6 |
GO:0051925 |
obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
| 0.0 |
0.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.4 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
0.5 |
GO:0070588 |
calcium ion transmembrane transport(GO:0070588) |
| 0.0 |
0.1 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.1 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.1 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.0 |
0.0 |
GO:0032095 |
regulation of response to food(GO:0032095) |
| 0.0 |
0.1 |
GO:0048839 |
inner ear development(GO:0048839) |
| 0.0 |
0.1 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.0 |
0.0 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.0 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.1 |
GO:0032367 |
intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.2 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.1 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.1 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.0 |
0.1 |
GO:0001942 |
hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
| 0.0 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.4 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) protein localization to mitochondrion(GO:0070585) establishment of protein localization to mitochondrion(GO:0072655) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.5 |
GO:0006302 |
double-strand break repair(GO:0006302) |
| 0.0 |
0.0 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
| 0.0 |
0.3 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.4 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.2 |
GO:0043506 |
regulation of JUN kinase activity(GO:0043506) |
| 0.0 |
0.1 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.1 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.0 |
0.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 |
2.6 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.0 |
0.1 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.0 |
0.1 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 |
0.7 |
GO:0000236 |
mitotic prometaphase(GO:0000236) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.0 |
GO:0014888 |
striated muscle adaptation(GO:0014888) |
| 0.0 |
0.1 |
GO:1901142 |
insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 0.0 |
0.1 |
GO:0045060 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.0 |
0.2 |
GO:1903426 |
regulation of nitric oxide biosynthetic process(GO:0045428) regulation of reactive oxygen species biosynthetic process(GO:1903426) |
| 0.0 |
0.0 |
GO:0032943 |
mononuclear cell proliferation(GO:0032943) |
| 0.0 |
0.1 |
GO:0021517 |
ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 |
0.2 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
| 0.0 |
1.3 |
GO:0000226 |
microtubule cytoskeleton organization(GO:0000226) |
| 0.0 |
0.1 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.1 |
GO:0051603 |
proteolysis involved in cellular protein catabolic process(GO:0051603) |
| 0.0 |
0.2 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.8 |
GO:0006816 |
calcium ion transport(GO:0006816) |
| 0.0 |
0.1 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 |
0.1 |
GO:0019883 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.1 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.0 |
0.2 |
GO:0050704 |
interleukin-1 beta secretion(GO:0050702) regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.0 |
0.2 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.0 |
0.0 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.0 |
0.0 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.5 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.1 |
GO:0032200 |
telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
| 0.0 |
0.1 |
GO:0044349 |
nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
| 0.0 |
0.1 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.0 |
0.1 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.1 |
GO:0072329 |
fatty acid catabolic process(GO:0009062) monocarboxylic acid catabolic process(GO:0072329) |
| 0.0 |
0.0 |
GO:0003077 |
obsolete negative regulation of diuresis(GO:0003077) |
| 0.0 |
0.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.3 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.1 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.0 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.0 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.0 |
1.4 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.1 |
GO:0007093 |
mitotic cell cycle checkpoint(GO:0007093) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 |
0.0 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.0 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.0 |
0.3 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.1 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 |
0.0 |
GO:0015670 |
carbon dioxide transport(GO:0015670) saliva secretion(GO:0046541) |
| 0.0 |
0.1 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.0 |
0.0 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.1 |
GO:0042102 |
positive regulation of T cell proliferation(GO:0042102) |
| 0.0 |
1.1 |
GO:0044839 |
G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
| 0.0 |
0.2 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.1 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.0 |
0.1 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.1 |
GO:0046631 |
alpha-beta T cell activation(GO:0046631) |
| 0.0 |
0.1 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.1 |
GO:0021549 |
cerebellum development(GO:0021549) |
| 0.0 |
0.1 |
GO:0061756 |
leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.0 |
0.6 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.1 |
GO:1903078 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 |
0.1 |
GO:0042472 |
inner ear morphogenesis(GO:0042472) |
| 0.0 |
0.0 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
1.3 |
GO:0006414 |
translational elongation(GO:0006414) |
